spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Proxcelan 

 HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
Devices Oncology
 HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing
 HSMN NewsFeed - 27 Jan 2010
IsoRay Hires Vice President of Research and Development
Devices Oncology Personnel
 HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
Devices Oncology
 HSMN NewsFeed - 3 Dec 2009
IsoRay Announces Iodine Distribution Agreement with GE Subsidiary, Oncura
Devices Oncology Distribution
 HSMN NewsFeed - 18 Nov 2009
IsoRay Announces Distribution Agreement in Canada
Devices Oncology Distribution
 HSMN NewsFeed - 18 Aug 2009
IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors
Devices Oncology FDA
 HSMN NewsFeed - 27 Feb 2008
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
Devices Personnel
 HSMN NewsFeed - 1 Nov 2007
New Studies Unveiled at ASTRO's 49th Annual Meeting of Radiation Oncology Specialists Support the Effectiveness of IsoRay Medical's Proxcelan(TM) for the Treatment of Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 1 Oct 2007
IsoRay Announces Global Strategic Alliance with IBt s.a.
Devices Oncology
 HSMN NewsFeed - 30 Aug 2007
IsoRay Medical, Inc., Set to Transfer Production of Proxcelan(TM) (Cesium-131) Brachytherapy Seeds to New Expanded Facilities in Richland
Devices Oncology
 HSMN NewsFeed - 9 Aug 2007
Leading Medical Centers Join Growing Number of Locations Offering IsoRay's Prostate Cancer Treatment Proxcelan(TM) Brachytherapy Seeds (Cesium-131)
Devices Oncology
 HSMN NewsFeed - 20 Jul 2007
IsoRay Medical, Inc. Introduces Branding of Cesium-131 as Proxcelan(TM) for Use in Prostate Cancer Brachytherapy
Devices Oncology
 HSMN NewsFeed - 20 Jul 2007
Scientific Abstracts on Newest Isotope Used in Brachytherapy for Prostate Cancer -- IsoRay's Proxcelan(TM) with Cesium-131
Devices Oncology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.